Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG: HuMax-CD4
DRUG: HuMax-CD4

Sponsor

Genmab